Fibroblast growth factor-1 (FGF-1) promotes adipogenesis by downregulation of carboxypeptidase A4 (CPA4)–a negative regulator of adipogenesis implicated in the modulation of local and systemic insulin sensitivity

Jingjing He, Daniel L. T Chen, Dorit Samocha-Bonet, Kevin R. Gillinder, Johanna L. Barclay, Graham W. Magor, Andrew C. Perkins, Jerry R Greenfield, Gongshe Yang, Jonathan P Whitehead

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)


Fibroblast growth factor-1 (FGF-1) promotes differentiation of human preadipocytes into mature adipocytes via modulation of a BMP and Activin Membrane-Bound Inhibitor (BAMBI)/Peroxisome proliferator-activated receptor (PPARγ)-dependent network. Here, we combined transcriptomic and functional investigations to identify novel downstream effectors aligned with complementary analyses of gene expression in human adipose tissue to explore relationships with insulin sensitivity. RNA-Seq and qRT-PCR analysis revealed significant down-regulation of carboxypeptidase A4 (CPA4) following FGF-1 treatment or induction of differentiation of human preadipocytes in a BAMBI/PPARγ-independent manner. siRNA-mediated knockdown of CPA4 resulted in enhanced differentiation of human preadipocytes. Furthermore, expression of CPA4 in subcutaneous adipose tissue correlated negatively with indices of local and systemic (liver and muscle) insulin sensitivity. These results identify CPA4 as a negative regulator of adipogenesis that is down-regulated by FGF-1 and a putative deleterious modulator of local and systemic insulin sensitivity. Further investigations are required to define the molecular mechanism(s) involved and potential therapeutic opportunities.

Original languageEnglish
Pages (from-to)210-216
Number of pages7
JournalGrowth Factors
Issue number5-6
Publication statusPublished - 1 Nov 2016
Externally publishedYes


  • carboxypeptidase
  • differentiation
  • FGF-1
  • obesity
  • preadipocyte

Cite this